Abstract Myeloid sarcoma is an extramedullary tumor seen most commonly in patients with acute myeloid leukemia and less frequently in chronic myeloid leukemia, myelodysplastic syndrome and rarely, in an isolated form without any other underlying malignancy. Malignant pleural effusion in hematological malignancies is rare when compared with solid tumors. We present an unusual case of myeloid sarcoma in which a mediastinal mass with pleural effusion was the initial presentation. A 27 year old gentleman presented with complaints of fever, chest pain and swelling in the anterior chest wall for 6 months. Examination revealed a lump measuring 5 9 5 cm on the left side of the chest wall. Hematological evaluation showed hemoglobin-14.2 g/dL, platelet count-233 9 10 9 /L, TLC-117 9 10 6 /L with normal differential counts. Contrast enhanced computerised tomography (CECT) confirmed the presence of a soft tissue mass in the superior mediastinum abutting against the chest wall. Core biopsy was suggestive of myeloid sarcoma and immunohistochemistry was positive for myeloperoxidase and negative for CD3, CD 20 and CD 23. Pleural fluid analysis showed the presence of malignant cells. Bone marrow examination did not show an excess of blasts. A final diagnosis of extramedullary myeloid sarcoma with malignant pleural effusion was made. The patient was given induction chemotherapy (3 ? 7 regimen) with daunorubicin and cytosine arabinoside. Repeat CECT done on day 28 showed complete resolution of pleural effusion and significant reduction in the size of mediastinal mass. The patient has successfully completed three cycles of consolidation therapy following which there has been complete resolution of the mass. He remains asymptomatic on close follow up.
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Case Report
A 27-year old gentleman presented with complaints of fever, chest pain and swelling in the anterior chest wall for 6 months. Examination showed presence of a non-tender lump (5 9 5 cm) on the left chest wall which was fixed to overlying skin. Laboratory investigations showed hemoglobin-14.2 g/dL, platelet count-233 9 10 9 /L and TLC-11.7 9 10 9 /L with differential count of 65 % neutrophils, 13 % lymphocytes, 6 % monocytes, 16 % eosinophils with normal RBC indices and peripheral blood smear. Chest X ray showed mediastinal widening with left sided moderate pleural effusion (Fig. 1) . CECT chest showed soft tissue mass in superior mediastinum abutting against the chest wall (Fig. 2) . Positron emission tomography (PET) scan showed increased FDG avid uptake in the superior mediastinum (Fig. 3) . A core biopsy from the mass was suggestive of myeloid sarcoma. Immunohistochemistry confirmed the presence of tumor cells that were positive for myeloperoxidase stain and negative for CD3, CD 20 and CD 23 (Fig. 4) . Pleural fluid staining showed scattered population of hematopoietic cells intermixed with reactive cells while high power view showed increased cellularity with abundant blasts, myelocytes, metamyelocytes, eosinophils, neutrophils and scattered myeloblasts ( 
Discussion
Pleural effusion secondary to leukemic cell infiltration is not a common phenomenon. In general, infective causes of pleural effusion are far commoner than malignant causes, of which hematological malignancies make up an even smaller portion. A retrospective analysis of pleural fluid cytological samples was performed at our institute by Awasthi et al. [1] . In this study, out of 898 samples of pleural fluid, only 164 cases were found positive for malignancy, the remainder being of infective etiologies. Further sub-categorization confirmed that only 30 cases were of hematological origin with the commonest etiology being non-hodgkin's lymphoma (20 cases) followed by acute lymphoblastic leukemia (four cases), multiple myeloma 
(four cases) and chronic myeloid leukemia (two cases). No case of acute myeloid leukemia was found. The two other major studies done by Cakir et al. [2] . Johnston et al. suggested similar findings [3] . These studies showed that malignant pleural effusion is an uncommon phenomenon in patients with hematological malignancies (Table 1 ). The incidence of malignant pleural effusion occurring in a patient with myeloid sarcoma in the absence of any detectable medullary disease is therefore, exceedingly rare and unusual. We performed a systematic review of all studies investigating myeloid sarcoma with leukemic pleural effusion published between 1977 and 2013. The National Library of Medicine database was searched using the MeSH terms ''Myeloid sarcoma'' and ''pleural effusion''. We limited the literature search to articles on human subjects and those written in English. Pleural effusions secondary to infectious processes, heart failure, renal failure or hypoalbuminemia were not included. We reviewed and limited our discussion to only pleural effusion with positive cytology for malignant cells. In total we found 13 related articles as per our criteria (Table 2) .
Lymph nodes, bone, skin, orbit and soft tissue are the most common sites of involvement by myeloid sarcoma however involvement of rare sites have also been reported [4, 5] . In our literature review we found that the most common extra medullary site of myeloid sarcoma was the mediastinum [6] [7] [8] [9] [10] followed by pleura [11] [12] [13] . McCarty et al. reported a case of a 33-year old man who developed myeloid sarcoma at two sites (mediastinum and paraspinal mass) within a span of 12 months along with right sided malignant pleural effusion [6] . Mediastinum (six cases) was the most common site of involvement among the nine cases of intrathoracic myeloid sarcoma studied by Takasugi et al. [9] . Malignant pleural effusion was noted only in a single case of a mediastinal myeloid sarcoma. Lo et al. [10] reported a patient with granulocytic sarcoma of the mediastinum who presented with esophageal obstruction and compressive symptoms. The involvement of rare sites like gingival [14] , peritoneum [11] , pericardium [15] , spine [6] , thymus [16] and the head of pancreas [17] have also been reported in literature.
Usually, myeloid sarcoma occurs in conjugation with previous or concurrent AML or in patients with other myeloid malignancies such as CML or MDS [18] . Rarely, myeloid sarcoma can be seen in patients without any evidence of hematologic disorders [19] .
Nine out of thirteen case reports reviewed by us had acute myeloid leukemia. Five cases had non-promyelocytic [7, 9, 10, 13, 15, 16] , two had acute promyelocytic leukemia [8, 20] and one had AML secondary to pre-existing MDS [11] . In the cases reviewed by us, we found that apart from our case there were four cases with biopsy proven myeloid sarcoma and malignant pleural effusion without concurrent acute myeloid leukemia. Three out of the four above mentioned cases had lung nodules with pleural involvement, gingival swelling and lesions in the head of pancreas [17] . Only one case had a mediastinal mass as seen in our patient [6] . Myeloid sarcoma may be considered as a herald or precursor of AML in some cases. Aggressive management of this tumor on the lines of AML with systemic chemotherapy is necessary as most patients may develop full blown AML if only local therapy or radiation alone is given. Imrie et al. reported that 71 % of patients diagnosed with myeloid sarcoma who did not receive anti leukemic chemotherapy subsequently developed AML within a median time of 7 months (21).
Conclusion
Isolated myeloid sarcoma in the absence of other features of acute myeloid leukemia is an unusual presentation. Management of myeloid sarcoma should be on the lines of systemic disease due to the high incidence of progression to AML in patients treated with local therapy alone. Malignant pleural effusions are rare in patients with AML. This case illustrates a rare presentation of a myeloid sarcoma presenting with a mediastinal mass and malignant pleural effusion.
